The regulatory asymmetry between topical and injectable in the 503A list reflects, in part, that asymmetry in the evidence
A fiber supplement such as psyllium husk can help bridge the gap
What the Research Shows Recent research on semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) has revealed concerning trends about body composition changes: A 2023 analysis of STEP trial data found that approximately 39% of weight lost on semaglutide was lean body mass 1 Research on tirzepatide showed similar patterns, with 30-40% of total weight loss coming from lean tissue 2 Comparative studies indicate GLP-1 users may lose more muscle than people losing weight through diet and exercise alone 3 For context: if you lose 50 pounds on a GLP-1 medication, 15-20 pounds might be muscle mass
Subcutaneous injection, typically 100300 mcg, 23 times daily - to mimic the natural pulsatility of GH secretion
Never puncture, incinerate, or throw in regular rubbish